About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

OEIS Outcome Data Registry | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT03058913

OEIS Outcome Data Registry

This registry is created under the sponsorship of the Outpatient Endovascular and Interventional Society (OEIS) to monitor the clinical course and treatment outcomes of patients undergoing office-base...

Lead sponsor: Outpatient Endovascular and Interventional Society•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Dhru Bhatt

CONTACT

8885486347 DBhatt@association-resources.com

Elizabeth Ouriel

CONTACT

2128786882 eouriel@syntactx.com

Sponsors

Lead Sponsor

Outpatient Endovascular and Interventional Society

Collaborators

Syntactx

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient is 18 years of age or older;
•Patient is identified as having undergone a percutaneous transluminal vascular intervention or attempted intervention, in an ambulatory (outpatient) facility, for the treatment of peripheral vascular disease within native arteries or bypass grafts, from the infrarenal aorta distally to the feet.

Exclusion Criteria

•Patient treated for a non-eligible condition or procedure
•Diagnostic procedures without intervention or attempted interventions
•Serious mental illness that might preclude subject's ability to comply with follow up
•Life expectancy of less than 6 months

Related studies

RECRUITINGPhase 3

Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease

NCT07223593 · Peripheral Arterial Disease

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

NCT06112171 · Peripheral Arterial Disease

Handgrip Training in Patients With Peripheral Artery Disease

NCT03663777 · Peripheral Arterial Disease

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

NCT07223437 · Peripheral Arterial Disease

Tele-assessment and Face-to-face Assessment of the 30-second Sit-stand Test in Peripheral Artery Disease

NCT07497360 · Peripheral Arterial Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 28, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment600,000

Start dateFeb 2017

Last updatedSep 28, 2022

Condition

Peripheral Arterial Disease

Locations shown

Outpatient Endovascular Interventional Society (OEIS)

Hoffman Estates, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions